| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 |
| filingDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eecbbeb0f8fccec85f613c1b4f8a7cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf247861bcc4e48aeaede3d5d10b751d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38ab8548dc6188365162d5fe3b4be73 |
| publicationDate |
2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2233285-C1 |
| titleOfInvention |
Highly tritium labeled [3h]-rapamycin |
| abstract |
FIELD: organic chemistry, labeled compounds. n SUBSTANCE: invention relates to a new tritium-labeled analogue of physiologically active compound, namely [ 3 H]-rapamycin of the formula (I): n n n n that is used in organic and bioorganic chemistry and in medicine as an immunosuppressor. Invention provides preparing analogue of physiologically active compound. n EFFECT: valuable properties of compound. n 1 cl, 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7576202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006071138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7538119-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007056175-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007056175-A2 |
| priorityDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |